Ocular Flashcards
Antibiotics
Sulfacetamide, fluoroquinolones, macrolides, amino glycides, polymyxins
Antifungal
Natamycin
Antihistamine
Emedastine difumurate 0.05%, epinastine HCL 0.05%, alcaftadine 0.25%, Azelastine 0.05%, Ketotifin fumurate
NSAIDs
Dicoflenac sodium, ketorolac tromethamine, Flurbiprofen sodium, bromfenac, bromfenac sodium, nepafenac
Glaucoma
Prostaglandins, beta blockers, alpha agonists, carbonic anhydrase inhibitors, topical
Macular degeneration
VEGF inhibitors
VEGF inhibitors
Pepgaptanib, bevicizumib, aflibercept
Cyclosporine Indications
Keratoconjunctivitis sicca
Cyclosporine MOA
Immunosuppressant; specified for treatment of keratoconjuntivitis sicca due to inflammation
Cyclosporine contraindications
Hypersensitivity, contact wearers
Cyclosporine AR
Burning
Pegaptanib indications
VEGF inhibitor for TX of macular degeneration
Pegaptanib AR
Blepharitis, conjunctivitis, increased IOP, photopsia…
Bevacizumab indications
Cancer, macular degeneration
Bevacizumab AR
High risk of infection from repetitive use of vial
Aflibercept indications
Macular degeneration
Aflibercept AR
Conjunctival hemorrhage, pain, cataract, floaters, bit real detachment, increased IOP
Lubricants
Cyclosporine, acetylcysteine
Prostaglandins
Latanoprost, travoprost, tafluprost, unoprostone, bimatoprost
Beta blockers
Timolol, levobunolol, carteolol, metipranolol, betaxolol
Alpha agonists
Apraclonidine, brimonidine, brimonidine/timolol
Beta blockers MOA
Decrease aqueous humor production 20-25%; beta-adrenergic antagonists
Alpha agonist MOA
Increase aqueous outflow 20-25%
Alpha agonist AR
Conjunctival injection, hyperemia, vision change, headache, fatigue
Carbonic anhydrase inhibitors
Acetazolamide, dorzolamide, dorzolamide/timolol, brinzolamide
Carbonic anhydrase inhibitors oral
Acetazolamide
Carbonic anhydrase inhibitors MOA
Decreases aqueous humor secretion by decreasing bicarbonate formation 15-20%
Cycloplegics
Anticholinergics. Dilate pupils by weakening ciliary muscles
Cycloplegics indication
Ulcers, uveitis, cycloplegic refraction
Mucolytic
Acetylcysteine
Acetylcysteine MOA
Breaks up mucus
Sulfacetamide 10% solution indication
Broad spectrum antibiotic. Treatment for bacterial conjunctivitis
Sulfacetamide MOA
Inhibits nucleic acid synthesis. Bacteriostatic
Sulfacetamide contraindications
Hypersensitivity
Sulfacetamide drug interaction
Silver
Fluoroquinolones
Besifloxacin, moxifloxacin, ofloxacin, levofloxacin .5 & 1.5, gatifloxacin, ciprofloxacin
Fluoroquinolones indications
Broad spectrum antibiotic for Bacterial conjunctivitis
Fluoroquinolones MOA
Inhibits DNA gyrase; bactericidal
Fluoroquinolones contraindications
Hypersensitivity
Fluoroquinolones AR
Burning, FBS, photophobia, blurred vision, tearing, dryness
Macrolides
Ezithromycin, azithromycin
Macrolides indications
Broad spectrum antibiotic for bacterial infections. Specificity for chlamydia and gonnorhea
Macrolides MOA
Inhibits bacterial protein synthesis; bacteriostatic
Macrolides contraindications
Hypersensitivity
Macrolides AR
Irritation, redness, hypersensitivity
Aminoglycides
Gentamicin, tobramycin, tobramycin/dexamethasone, tobramycin/fluorometholone
Aminoglycides MOA
Binds ribosomal RNA disrupting translation. Bactericidal
Aminoglycides indications
Broad spectrum antibiotic for ocular bacterial infections associated with inflammation
Aminoglycides contraindications
Hypersensitivity, dexamethasone will make fungal infections worse
Aminoglycides AR
Ulcers, irritation, conjunctivitis, thrombocytopenic purpura
Polymyxins
Trimethoprim, bacitracin
Natamycin indication
Antifungal
Natamycin MOA
Alters fungi membrane permeability. Fungicidal
Antihistamines
Emedastine difumurate, epinastine HCL, alcaftadine, Azelastine, Ketotifin fumurate
Antihistamine MOA
H1 receptor antagonist
NSAIDs
Dicloflenac sodium, ketorolac tromethamine, Flurbiprofen sodium, bromfenac, bromfenac sodium, nepafenac
NSAID indications
Pain and inflammation post-op, corneal abrasion, blepharitis
Bromfenac contraindications
Sulfite allergy
NSAIDs AR
Delayed healing, keratitis, corneal melt, burning, lacrimation, FBS, increased IOP
Prostaglandins indications
First line of TX in patients with increased IOP reduces IOP 20-25%
Prostaglandin MOA
Increases aqueous humor outflow
Prostaglandin AR
Hyperpigmentation, lash growth, uveitis, herpes virus activation